Lb Pharmaceuticals Cash Flow Statement (2024-2026) | LBRX

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2024 Dec2024 Mar2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter) -14.18M-5.07M-5.31M-3.56M-11.47M-19.05M
Depreciation and Depletion (Quarter) 0.08M0.08M
Share-based Compensation (Quarter) 0.00M0.63M0.11M2.34M2.57M
Gains from Sales and Divestitures (Quarter) 6.55M
Gains from Investment Securities (Quarter) 1.81M1.83M
Non-cash Items (Quarter) 0.63M17.23M24.42M
Cash from Operations (Quarter) -5.67M-8.13M-18.10M-23.29M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.06M0.01M-0.02M-0.02M
Depreciation & Amortization (CF) (Quarter) 0.08M0.08M
Change in Working Capital
Change in Accured Expenses (Quarter) -2.92M-2.89M1.97M3.46M
Investing Activities
Capital Expenditures (Quarter) 0.24M0.02M0.04M0.03M
Change in Acquisitions & Divestments (Quarter) 7.26M2.50M0.00M
Cash from Investing Activities (Quarter) 13.54M4.98M-0.04M-0.03M
Financing Activities
Other financing activities (Quarter) 25.43M
Change in Capital Stock
Shares Issued (Quarter) 100.00M
Misc.
Cash from Financing Activities (Quarter) -1.17M93.83M
Change in Cash (Quarter) 7.87M-3.15M-19.31M70.51M
Free Cash Flow (Quarter) -5.90M-8.15M-18.14M-23.32M
Net Cash Flow (Quarter) 7.87M-3.15M-19.31M70.51M